Literature DB >> 19322081

Advances in quality of life and symptom management for head and neck cancer patients.

Barbara A Murphy1.   

Abstract

PURPOSE OF REVIEW: Head and neck cancer and its therapy are associated with marked symptom burden, functional impairment and decreased quality of life. This review will encompass the recent studies addressing supportive care issues facing head and neck cancer patients. RECENT
FINDINGS: Although it has long been recognized that head and neck cancer therapy results in significant acute toxicity, it is now becoming recognized that the late effects of therapy are equally problematic. In addition, it is clear that many acute and late effects of therapy, including oral health issues, nutritional deficiencies and the role of physical therapy and rehabilitation, are under recognized and under studied. Although supporting data are scant, allied health professions play a critical role in managing acute and late effects of therapy.
SUMMARY: Healthcare providers must take an active role in the evaluation and management of the acute and late effects of therapy. Referral for appropriate supportive care and rehabilitative services is critical in order to minimize the acute and late effects of therapy and to maximize long-term function.

Entities:  

Mesh:

Year:  2009        PMID: 19322081     DOI: 10.1097/CCO.0b013e32832a230c

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  17 in total

1.  Tolerance of Radical Radiotherapy Among Elderly Head and Neck Cancer Patients.

Authors:  A S Kirthi Koushik; K S Sandeep; M G Janaki; Ram Charith Alva; Irappa Vithoba Madabhavi
Journal:  Indian J Surg Oncol       Date:  2020-01-02

2.  [Measuring the world of quality of life].

Authors:  S Maune; U Geisthoff
Journal:  HNO       Date:  2009-09       Impact factor: 1.284

3.  Outcomes evaluation of a weekly nurse practitioner-managed symptom management clinic for patients with head and neck cancer treated with chemoradiotherapy.

Authors:  Heidi Mason; Mary Beth DeRubeis; Jared C Foster; Jeremy M G Taylor; Francis P Worden
Journal:  Oncol Nurs Forum       Date:  2013-11       Impact factor: 2.172

4.  Prevalence and correlates of symptoms and uncertainty in illness among head and neck cancer patients receiving definitive radiation with or without chemotherapy.

Authors:  Mary Ellen Haisfield-Wolfe; Deborah B McGuire; Karen Soeken; Jeanne Geiger-Brown; Bruce De Forge; Mohan Suntharalingam
Journal:  Support Care Cancer       Date:  2011-10-04       Impact factor: 3.603

5.  Health-related quality of life of head and neck cancer patients with successful oncological treatment.

Authors:  V Loimu; A A Mäkitie; L J Bäck; H Sintonen; P Räsänen; R Roine; K Saarilahti
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-07-02       Impact factor: 2.503

6.  Human Papillomavirus and Oropharyngeal Squamous Cell Carcinoma of the Head and Neck: A Growing Epidemic.

Authors:  Jessica Bauman; Lori Wirth
Journal:  Adolesc Med State Art Rev       Date:  2014-08

7.  Longitudinal quality of life in Turkish patients with head and neck cancer undergoing radiotherapy.

Authors:  Esra Citak; Zeliha Tulek
Journal:  Support Care Cancer       Date:  2013-03-09       Impact factor: 3.603

8.  The linguistic validation process of the Vanderbilt Head and Neck Symptom Survey - Italian Version (VHNSS-IT).

Authors:  Marta Maddalo; Michela Buglione; Nadia Pasinetti; Luca Triggiani; Loredana Costa; Stefano M Magrini; Barbara A Murphy
Journal:  Radiol Med       Date:  2019-11-29       Impact factor: 3.469

Review 9.  Treatment of older patients with head and neck cancer: a review.

Authors:  Noam A VanderWalde; Mary Fleming; Jared Weiss; Bhishamjit S Chera
Journal:  Oncologist       Date:  2013-05-01

10.  Computerized monitoring of patient-reported speech and swallowing problems in head and neck cancer patients in clinical practice.

Authors:  Ingrid C Cnossen; Remco de Bree; Rico N P M Rinkel; Simone E J Eerenstein; Derek H F Rietveld; Patricia Doornaert; Jan Buter; Johannes A Langendijk; C René Leemans; Irma M Verdonck-de Leeuw
Journal:  Support Care Cancer       Date:  2012-03-07       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.